Giovanni Magni Biography and Net Worth

Giovanni Magni is Executive Vice President, Chief Strategy Officer of the Company. He was appointed Executive Vice President, Chief Strategy Officer in August 2014. Previously, he was Executive Vice President of International Sales from 2012 to 2014 and Vice President and International Sales Manager from 2004 to 2012. Prior to that, he held various positions within Bio-Rad since joining us in 1995, including Diagnostic Division Manager, Southern Europe and Diagnostics Group Operation Manager, France.

What is Giovanni Magni's net worth?: The estimated net worth of Giovanni Magni is at least $3.62 million as of August 18th, 2020. Mr. Magni owns 12,435 shares of Bio-Rad Laboratories stock worth more than $3,615,849 as of April 18th. This net worth estimate does not reflect any other assets that Mr. Magni may own. Learn More about Giovanni Magni's net worth.
How do I contact Giovanni Magni?: The corporate mailing address for Mr. Magni and other Bio-Rad Laboratories executives is 1000 ALFRED NOBEL DRIVE, HERCULES CA, 94547. Bio-Rad Laboratories can also be reached via phone at (510) 724-7000 and via email at [email protected]. Learn More on Giovanni Magni's contact information.
Has Giovanni Magni been buying or selling shares of Bio-Rad Laboratories?: Giovanni Magni has not been actively trading shares of Bio-Rad Laboratories within the last three months. Most recently, Giovanni Magni sold 2,382 shares of the business's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $518.81, for a transaction totalling $1,235,805.42. Following the completion of the sale, the executive vice president now directly owns 12,435 shares of the company's stock, valued at $6,451,402.35. Learn More on Giovanni Magni's trading history.
Who are Bio-Rad Laboratories' active insiders?: Bio-Rad Laboratories' insider roster includes Michael Crowley (EVP), Ilan Daskal (CFO), Timothy Ernst (EVP), Ronald Hutton (VP), Giovanni Magni (EVP), Ajit Ramalingam (CAO), and Annette Tumolo (EVP). Learn More on Bio-Rad Laboratories' active insiders.
Are insiders buying or selling shares of Bio-Rad Laboratories?: In the last twelve months, insiders at the medical research company sold shares 7 times. They sold a total of 8,190 shares worth more than $2,870,551.60. The most recent insider tranaction occured on February, 27th when EVP Michael Crowley sold 3,000 shares worth more than $1,008,000.00. Insiders at Bio-Rad Laboratories own 17.5% of the company. Learn More about insider trades at Bio-Rad Laboratories.
Information on this page was last updated on 2/27/2024.

Giovanni Magni Insider Trading History at Bio-Rad Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/18/2020	Sell	2,382	$518.81	$1,235,805.42	12,435
11/14/2017	Sell	2,400	$253.01	$607,224.00	9,251

Giovanni Magni Buying and Selling Activity at Bio-Rad Laboratories

Bio-Rad Laboratories Company Overview

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Today's Range

Now: $290.78

$290.40

$299.22

50 Day Range

MA: $331.66

$290.78

$351.99

2 Week Range

Now: $290.78

$261.59

$489.36

Volume

214,091 shs

Average Volume

199,335 shs

Market Capitalization

$8.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87

Urgent alert: open this for a huge profit potential

From Timothy Sykes | Ad

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here